Nicola Amodio

Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity

Nicola Amodio, Maria Angelica Stamato, Giada Juli et al. · Leukemia · 2018 · 252 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <i>In Vitro</i> and <i>In Vivo</i> Evidence

Maria Teresa Di Martino, Emanuela Leone, Nicola Amodio et al. · Clinical Cancer Research · 2012 · 243 citations · Full text

Medicine, Cancer Biology, Oncology +16

Targeting miR-21 Inhibits <i>In Vitro</i> and <i>In Vivo</i> Multiple Myeloma Cell Growth

Emanuela Leone, Eugenio Morelli, Maria Teresa Di Martino et al. · Clinical Cancer Research · 2013 · 217 citations · Full text

Medicine, Cancer Biology, Oncology +16

miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease

Marco Rossi, Maria Rita Pitari, Nicola Amodio et al. · Journal of Cellular Physiology · 2012 · 186 citations

Medicine, Oral Pathology, Bone Metabolism +16

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

Nicola Amodio, Maria Teresa Di Martino, Umberto Foresta et al. · Cell Death and Disease · 2012 · 161 citations · Full text

Life Sciences, Oncology, Pharmacology +17